Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
Conditions: Chronic Myeloid Leukemia Interventions: Other: Asciminib Sponsors: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | France Health | Leukemia | Research | Study